| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.087 | 0.006 |